Senior Director, R&D Strategy Execution & Transformation

BeiGene

3d•$223,400 - $293,400

About The Position

BeOne Medicines is seeking a highly capable, hands-on leader to drive strategic initiatives and transformation across its global Research & Development organization. Reporting to the VP of R&D Strategy & Operations, this individual will translate R&D strategic priorities into tangible outcomes, lead complex cross-functional initiatives, establish effective program management structures, and strengthen organizational execution. This highly visible role calls for strategic problem-solving, operational discipline, sound business judgment, and the ability to influence stakeholders across a global, matrixed organization. The successful candidate will help shape how BeOne executes its R&D strategy and accelerates the development of innovative medicines. The position leads high-priority transformation initiatives from strategy through implementation; establishes program management offices and governance structures; improves operating models, processes, organizational effectiveness, and productivity; and supports R&D planning, goal-setting, performance management, and executive decision-making. It also develops leadership communications and contributes to strategic problem-solving as organizational priorities evolve.

Requirements

Experience in biopharma, life sciences consulting, corporate strategy, transformation, R&D operations, or a related field; consulting and industry experience are equally valued.
Strong understanding of the pharmaceutical or biotechnology industry and the R&D value chain.
Demonstrated success independently leading complex cross-functional initiatives, transformations, PMOs, or organizational change programs through implementation.
Ability to translate ambiguous objectives into structured workplans and drive execution through stakeholders without direct authority.
Strong analytical, problem-solving, organizational, and project management skills, with excellent attention to detail and follow-through.
Excellent executive communication and story-lining capabilities, including the ability to independently develop senior leadership materials.
High emotional intelligence, sound judgment, and ability to navigate complex global and matrixed organizations.
Entrepreneurial, proactive, hands-on, and adaptable; comfortable operating in a fast-paced environment with evolving priorities.
Bachelor's degree required.
PhD with 6 years of experience or a master's degree with 8 years of experience is preferred; exceptions may be made for candidates with relevant experience.

Nice To Haves

Direct drug development or oncology experience.
Advanced degree preferred.

Responsibilities

Lead high-priority R&D transformation initiatives from strategy through implementation, ensuring measurable outcomes.
Establish and lead strategic program management offices, including workstream design, milestones, governance, risk management, and performance tracking.
Drive cross-functional alignment and accountability across Research, Development, and enabling functions; proactively resolve issues and escalate critical decisions.
Identify opportunities to improve R&D operating models, processes, organizational effectiveness, and productivity, and design and implement sustainable solutions.
Support the design and continuous improvement of R&D governance, strategic planning, goal-setting, and performance management processes.
Establish practical management systems and operating cadences that strengthen decision-making, transparency, and follow-through.
Partner with functional leaders to translate R&D-wide priorities into actionable plans, clear ownership, and measurable outcomes.
Partner with R&D leadership to address complex strategic and operational challenges.
Develop executive communications, decision materials, and progress updates that translate complex information into actionable insights.
Support leadership forums, strategic reviews, and high-priority activities of the R&D head office.
Contribute to strategic problem-solving and new initiatives as organizational priorities evolve.